Alamar Biosciences Files Initial Ownership Statement
Ticker: ALMR · Form: 3 · Filed: Apr 17, 2026
Sentiment: neutral
Topics: insider-filing, ownership
TL;DR
Alamar Biosciences just filed a Form 3 - initial ownership report. Keep an eye on this.
AI Summary
On April 16, 2026, Alamar Biosciences, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. This filing indicates the initial reporting of ownership for securities related to the company. Ian W. Ratcliffe, associated with the issuer, is listed with a CIK of 0001304782.
Why It Matters
This Form 3 filing marks the initial public disclosure of beneficial ownership of securities for Alamar Biosciences, Inc., providing transparency for investors.
Risk Assessment
Risk Level: low — A Form 3 filing is a standard initial disclosure and does not inherently indicate increased risk.
Key Players & Entities
- Alamar Biosciences, Inc. (company) — Issuer
- Ian W. Ratcliffe (person) — Reporting Person
- 0001304782 (company) — CIK for Ian W. Ratcliffe
- 0002104204 (company) — CIK for Alamar Biosciences, Inc.
FAQ
What type of filing is this?
This is a Form 3, an initial statement of beneficial ownership of securities.
When was the filing date?
The filing date was April 16, 2026.
Who is listed as a reporting person?
Ian W. Ratcliffe is listed as a reporting person.
What is the CIK for Alamar Biosciences, Inc.?
The CIK for Alamar Biosciences, Inc. is 0002104204.
What is the business address of Alamar Biosciences, Inc.?
The business address is 47071 BAYSIDE PARKWAY FREMONT CA 94538.
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 17, 2026 by Ian W. Ratcliffe regarding Alamar Biosciences, Inc. (ALMR). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.